论文部分内容阅读
目的阐明石油职工人群中体质指数与代谢综合征之间的关系。方法通过健康体检完成了1914例,其中男1166例,年龄22～56(36.9±6.3)岁;女748例,年龄20～53(35±5.7)岁,以中华医学会糖尿病学分会制定的MS工作定义为标准,按照BMI进行分层,分析不同BMI人群中MS的患病率及各项代谢指标的异常情况。结果MS总患病率为26.9%(515/1914),其中男性为35.8%(418/1166),女性为12.4%(93/748),男性明显高于女性(χ2=127.7,P<0.01)。随着BMI的增加,MS及各代谢异常组分数的患病率也随之增高。BMI<25组MS患病率为5.1%(57/1124),其中男为9.5%,女为1.7%,男性明显高于女性(χ2=34.7,P<0.01)。BMI≥25组MS患病率57.8%(458/792),其中男为55.0%,女为74.1%,女性高于男性(χ2=14.8,P<0.01)。两组间相比,BMI≥25组MS患病率明显高于BMI<25组(P<0.01),男性BMI≈23,女性BMI≈24时,MS患病率开始升高。结论随着BMI的增加,各种代谢异常组分数也逐渐增加,MS患病率也逐渐增加,MS患病率最易发生心、脑、肾等重要脏器病变。
Objective To clarify the relationship between body mass index and metabolic syndrome in petroleum workers population. Methods A total of 1914 patients were enrolled in this study. Among them, 1166 were male, aged from 36 to 56 years old (36.9 ± 6.3) years old; 748 were female, ranging in age from 20 to 53 (35 ± 5.7) years old. The MS The work was defined as a standard, stratified according to BMI, and analyzed the prevalence of MS and the abnormalities of various metabolic indexes in different BMI populations. Results The overall prevalence of MS was 26.9% (515/1914), of which 35.8% (418/1166) were male and 12.4% (93/748) were female, which was significantly higher in males than in females (χ2 = 127.7, P <0.01) . With the increase of BMI, the prevalence of MS and abnormal metabolic components also increased. The prevalence of MS was 5.1% (57/1124) in BMI <25, with 9.5% of men and 1.7% of women, significantly higher in males than in females (χ2 = 34.7, P <0.01). The prevalence of MS in BMI≥25 group was 57.8% (458/792), of which 55.0% were male and 74.1% were female, higher than male (χ2 = 14.8, P <0.01). The prevalence of MS in BMI≥25 group was significantly higher than that in BMI <25 group (P <0.01), and the prevalence of MS in male BMI ≈23 and female BMI ≈24 was higher than that in the two groups. Conclusions With the increase of BMI, the number of various metabolic abnormalities groups also gradually increases, and the prevalence of MS also gradually increases. The prevalence of MS is most likely to occur in vital organs such as heart, brain and kidney.